tiprankstipranks
Advertisement
Advertisement
BTIG says others may be interested in Apogee Therapeutics
PremiumThe FlyBTIG says others may be interested in Apogee Therapeutics
3d ago
Asad Haider Reiterates Hold on PFE, Keeps 12-Month Price Target Unchanged at $26 Amid CFO Transition and Clinical Upside Uncertainty
Premium
Ratings
Asad Haider Reiterates Hold on PFE, Keeps 12-Month Price Target Unchanged at $26 Amid CFO Transition and Clinical Upside Uncertainty
4d ago
AI Models Turn More Constructive on Pfizer as Post-COVID Reset Progresses
Premium
AI Analyst Ratings
AI Models Turn More Constructive on Pfizer as Post-COVID Reset Progresses
6d ago
Option traders moderately bearish in Pfizer with shares up 0.29%
PremiumThe FlyOption traders moderately bearish in Pfizer with shares up 0.29%
9d ago
CMS proposes to lock in lower prices in Medicare drug price negotiation program
Premium
The Fly
CMS proposes to lock in lower prices in Medicare drug price negotiation program
10d ago
Moderately bullish activity in Pfizer with shares up 2.21%
Premium
The Fly
Moderately bullish activity in Pfizer with shares up 2.21%
14d ago
Pfizer says FDA approves expanded indication for Hympavzi
PremiumThe FlyPfizer says FDA approves expanded indication for Hympavzi
17d ago
Pfizer presents results from Phase 2b studies of berobenatide
Premium
The Fly
Pfizer presents results from Phase 2b studies of berobenatide
17d ago
Acting FDA head vows to block political interference, Endpoint News says
Premium
The Fly
Acting FDA head vows to block political interference, Endpoint News says
21d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100